USPTO 2015–2025 USPTO PatentsView Foreign Corporation

SAMSUNG MEDISON CO., LTD.

USPTO PatentsView assignee record — 439 granted patents across 56 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

439
Total patents granted
56
CPC technology areas
15.8
Avg claims per patent
-26%
5-year filing velocity

Portfolio overview

SAMSUNG MEDISON CO., LTD. has been granted 439 US utility patents between 2015 and 2025, placing SAMSUNG MEDISON CO., LTD. at rank #1,000 across all assignees tracked by PlainPatent. This portfolio spans 56 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.8 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a Foreign Corporation, SAMSUNG MEDISON CO., LTD. is one of the broader-portfolio assignees in the PatentsView dataset. The composite Innovation Score of 59.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 186 grants, compared with 253 in the 2015–2019 window — a -26% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. SAMSUNG MEDISON CO., LTD.'s 15.8 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 56 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark SAMSUNG MEDISON CO., LTD. against peers pursuing similar technology classes.

How does SAMSUNG compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows SAMSUNG holds 439 patents — placing it at rank #1,000 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2015–2025

020406080 20152016201720182019202020212022202320242025 13
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
SAMSUNG MEDISON CO., LTD. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 50 11.4%
2016 50 11.4%
2017 46 10.5%
2018 43 9.8%
2019 64 14.6%
2020 45 10.3%
2021 34 7.7%
2022 39 8.9%
2023 36 8.2%
2024 19 4.3%
2025 13 3.0%

Which technologies does SAMSUNG MEDISON CO., LTD. patent most?

Top 15 of 56 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Declining

Where it ranks

Overall rank by patents

#1,000

Across all tracked assignees

Innovation Score

59.9 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does SAMSUNG MEDISON CO., LTD. hold?
SAMSUNG MEDISON CO., LTD. holds 439 US granted patents filed between 2015 and 2025, spanning 56 technology areas.
What is SAMSUNG MEDISON CO., LTD.'s Innovation Score?
SAMSUNG MEDISON CO., LTD. has an Innovation Score of 59.9 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does SAMSUNG MEDISON CO., LTD. focus on?
SAMSUNG MEDISON CO., LTD.'s top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 387 patents. The company has filed patents in 56 CPC subclasses total.
Is SAMSUNG MEDISON CO., LTD.'s patent filing rate increasing or decreasing?
SAMSUNG MEDISON CO., LTD.'s recent filing velocity is -26% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for SAMSUNG MEDISON CO., LTD.'s patents?
SAMSUNG MEDISON CO., LTD.'s patents average 15.8 claims each. This falls within the standard range, providing solid legal coverage.
How is the SAMSUNG MEDISON CO., LTD. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope